4D Molecular Therapeutics IncNASDAQ:FDMT
- LAST PRICE25.1500
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots24.6600/ 1
- Ask / Lots26.6000/ 2
- Open / Previous Close25.3800 / 25.1500
- Day Range
- 52 Week Range
- Volume414,374
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | FDMT |
|---|---|---|
| 09:32 ET | 3586 | 25.49 |
| 09:34 ET | 1167 | 25.22 |
| 09:36 ET | 900 | 25.31 |
| 09:38 ET | 400 | 25.38 |
| 09:39 ET | 400 | 25.475 |
| 09:41 ET | 400 | 25.485 |
| 09:43 ET | 100 | 25.53 |
| 09:45 ET | 300 | 25.59 |
| 09:48 ET | 1822 | 25.43 |
| 09:50 ET | 1100 | 25.34 |
| 09:52 ET | 2801 | 25.2 |
| 09:54 ET | 900 | 25.23 |
| 09:56 ET | 1200 | 25.17 |
| 09:57 ET | 2037 | 25.27 |
| 09:59 ET | 764 | 25.57 |
| 10:01 ET | 2437 | 25.78 |
| 10:08 ET | 1212 | 25.5567 |
| 10:10 ET | 100 | 25.62 |
| 10:12 ET | 1015 | 25.67 |
| 10:15 ET | 800 | 25.55 |
| 10:19 ET | 300 | 25.54 |
| 10:21 ET | 200 | 25.44 |
| 10:24 ET | 100 | 25.385 |
| 10:26 ET | 400 | 25.42 |
| 10:28 ET | 469 | 25.35 |
| 10:30 ET | 1000 | 25.51 |
| 10:33 ET | 200 | 25.475 |
| 10:37 ET | 593 | 25.42 |
| 10:39 ET | 1000 | 25.4925 |
| 10:42 ET | 100 | 25.475 |
| 10:44 ET | 600 | 25.42 |
| 10:46 ET | 800 | 25.405 |
| 10:51 ET | 200 | 25.42 |
| 10:53 ET | 100 | 25.37 |
| 10:57 ET | 400 | 25.29 |
| 11:00 ET | 100 | 25.26 |
| 11:02 ET | 200 | 25.23 |
| 11:04 ET | 100 | 25.215 |
| 11:06 ET | 300 | 25.265 |
| 11:08 ET | 1351 | 25.44 |
| 11:09 ET | 100 | 25.495 |
| 11:18 ET | 200 | 25.55 |
| 11:20 ET | 875 | 25.52 |
| 11:22 ET | 100 | 25.515 |
| 11:24 ET | 744 | 25.61 |
| 11:29 ET | 700 | 25.58 |
| 11:31 ET | 200 | 25.585 |
| 11:33 ET | 400 | 25.685 |
| 11:36 ET | 300 | 25.65 |
| 11:40 ET | 300 | 25.61 |
| 11:44 ET | 300 | 25.58 |
| 11:45 ET | 100 | 25.57 |
| 11:47 ET | 2094 | 25.51 |
| 11:49 ET | 100 | 25.545 |
| 11:51 ET | 1350 | 25.46 |
| 11:54 ET | 700 | 25.47 |
| 11:56 ET | 200 | 25.45 |
| 12:00 ET | 100 | 25.44 |
| 12:05 ET | 400 | 25.3975 |
| 12:07 ET | 200 | 25.38 |
| 12:09 ET | 996 | 25.4 |
| 12:12 ET | 500 | 25.41 |
| 12:16 ET | 300 | 25.475 |
| 12:20 ET | 100 | 25.54 |
| 12:21 ET | 100 | 25.6 |
| 12:23 ET | 2363 | 25.71 |
| 12:25 ET | 300 | 25.79 |
| 12:27 ET | 100 | 25.8 |
| 12:30 ET | 300 | 25.8 |
| 12:32 ET | 778 | 25.78 |
| 12:34 ET | 4972 | 25.845 |
| 12:36 ET | 500 | 25.87 |
| 12:38 ET | 200 | 25.865 |
| 12:39 ET | 2350 | 25.83 |
| 12:41 ET | 100 | 25.865 |
| 12:43 ET | 100 | 25.865 |
| 12:45 ET | 820 | 25.89 |
| 12:48 ET | 400 | 25.875 |
| 12:50 ET | 800 | 25.8 |
| 12:52 ET | 100 | 25.795 |
| 12:54 ET | 779 | 25.73 |
| 12:57 ET | 200 | 25.68 |
| 12:59 ET | 600 | 25.64 |
| 01:01 ET | 384 | 25.61 |
| 01:03 ET | 100 | 25.575 |
| 01:06 ET | 300 | 25.58 |
| 01:08 ET | 200 | 25.57 |
| 01:10 ET | 350 | 25.565 |
| 01:14 ET | 100 | 25.56 |
| 01:15 ET | 1050 | 25.51 |
| 01:17 ET | 300 | 25.51 |
| 01:19 ET | 200 | 25.48 |
| 01:21 ET | 400 | 25.495 |
| 01:24 ET | 100 | 25.46 |
| 01:26 ET | 400 | 25.46 |
| 01:30 ET | 1636 | 25.58 |
| 01:32 ET | 200 | 25.6 |
| 01:33 ET | 1366 | 25.46 |
| 01:39 ET | 400 | 25.48 |
| 01:42 ET | 500 | 25.45 |
| 01:44 ET | 200 | 25.445 |
| 01:46 ET | 1000 | 25.4 |
| 01:48 ET | 1232 | 25.384 |
| 01:50 ET | 500 | 25.4 |
| 01:51 ET | 597 | 25.43 |
| 01:53 ET | 100 | 25.4 |
| 01:55 ET | 100 | 25.43 |
| 01:57 ET | 800 | 25.45 |
| 02:00 ET | 700 | 25.36 |
| 02:02 ET | 300 | 25.34 |
| 02:04 ET | 913 | 25.34 |
| 02:06 ET | 800 | 25.28 |
| 02:08 ET | 100 | 25.335 |
| 02:09 ET | 800 | 25.37 |
| 02:11 ET | 200 | 25.3725 |
| 02:13 ET | 400 | 25.41 |
| 02:15 ET | 1909 | 25.45 |
| 02:20 ET | 500 | 25.47 |
| 02:22 ET | 300 | 25.44 |
| 02:24 ET | 600 | 25.42 |
| 02:26 ET | 250 | 25.3406 |
| 02:29 ET | 100 | 25.38 |
| 02:31 ET | 300 | 25.34 |
| 02:33 ET | 400 | 25.28 |
| 02:36 ET | 452 | 25.3 |
| 02:38 ET | 100 | 25.25 |
| 02:40 ET | 300 | 25.32 |
| 02:42 ET | 1247 | 25.21 |
| 02:44 ET | 200 | 25.2 |
| 02:45 ET | 300 | 25.26 |
| 02:47 ET | 1605 | 25.285 |
| 02:54 ET | 1034 | 25.26 |
| 02:56 ET | 100 | 25.265 |
| 02:58 ET | 300 | 25.31 |
| 03:00 ET | 200 | 25.34 |
| 03:02 ET | 300 | 25.29 |
| 03:03 ET | 800 | 25.18 |
| 03:05 ET | 400 | 25.21 |
| 03:07 ET | 1086 | 25.245 |
| 03:09 ET | 500 | 25.235 |
| 03:12 ET | 100 | 25.235 |
| 03:14 ET | 901 | 25.2 |
| 03:16 ET | 700 | 25.17 |
| 03:18 ET | 3800 | 25.245 |
| 03:20 ET | 3200 | 25.25 |
| 03:21 ET | 2826 | 25.21 |
| 03:23 ET | 128 | 25.19 |
| 03:25 ET | 400 | 25.17 |
| 03:27 ET | 26700 | 25.3 |
| 03:30 ET | 2211 | 25.26 |
| 03:32 ET | 1900 | 25.265 |
| 03:34 ET | 900 | 25.265 |
| 03:36 ET | 2600 | 25.28 |
| 03:38 ET | 6589 | 25.28 |
| 03:39 ET | 1451 | 25.275 |
| 03:41 ET | 400 | 25.275 |
| 03:43 ET | 3600 | 25.24 |
| 03:45 ET | 36499 | 25.34 |
| 03:48 ET | 5026 | 25.25 |
| 03:50 ET | 4803 | 25.22 |
| 03:52 ET | 5993 | 25.17 |
| 03:54 ET | 1666 | 25.17 |
| 03:56 ET | 4768 | 25.1 |
| 03:57 ET | 6811 | 25.155 |
| 03:59 ET | 14492 | 25.15 |
May 13, 2024
DJ 4D Molecular Therapeutics Price Target Maintained With a $36.00/Share by HC Wainwright & Co., from 6:55AM ET on Monday May 13, 2024 by Dow Jones
6:55AM ET on Monday May 13, 2024 by Dow Jones
May 9, 2024
4DMT Reports First Quarter 2024 Financial Results and Operational Highlights, from 4:05PM ET on Thursday May 09, 2024 by Dow Jones
4:05PM ET on Thursday May 09, 2024 by Dow JonesPress Release: 4DMT Reports First Quarter 2024 Financial Results and Operational Highlights, from 4:05PM ET on Thursday May 09, 2024 by Dow Jones
4:05PM ET on Thursday May 09, 2024 by Dow Jones
May 8, 2024
May 7, 2024
4DMT to Participate in Upcoming Investor Conference, from 8:00AM ET on Tuesday May 07, 2024 by Dow Jones
8:00AM ET on Tuesday May 07, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
4D Molecular Therapeutics Inc | 1.3B | -10.7x | --- |
Silence Therapeutics PLC | 1.0B | -17.9x | --- |
Spyre Therapeutics Inc | 1.3B | -0.5x | --- |
Akero Therapeutics Inc | 1.3B | -5.7x | --- |
Belite Bio Inc | 1.4B | -38.7x | --- |
Cullinan Therapeutics Inc | 1.4B | -7.7x | --- |
Company Information
4D Molecular Therapeutics, Inc. is a clinical-stage genetic medicines company focused on unlocking the full potential of genetic medicines to treat diseases in ophthalmology and pulmonology. The Company has a portfolio of genetic medicine product candidates, with five product candidates in clinical trials in seven patient populations: 4D-150 for the treatment of wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME), 4D-710 for the treatment of cystic fibrosis lung disease (both in modulator ineligible and eligible populations), 4D-310 for the treatment of Fabry disease cardiomyopathy, 4D-125 for the treatment of X-linked retinitis pigmentosa (XLRP), and 4D-110 for the treatment of choroideremia. In addition, it has two product candidates in preclinical development: 4D-175 for geographic atrophy (GA) and 4D-725 for alpha-1 antitrypsin deficiency lung disease.
Contact Information
- Headquarters
- 5858 Horton Street #455, EmeryvilleEMERYVILLE, CA, United States 94608
- Phone
- 510-505-2680
- Fax
- 302-655-5049
Executives
- Executive Chairman of the Board
- John Milligan
- President, Chief Operating Officer
- Fariborz Kamal
- Chief Executive Officer, Co-Founder, Director
- David Kirn
- Chief Financial and Business Officer
- Uneek Mehra
- Chief Medical Officer
- Robert Kim
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.3B |
|---|---|
Revenue (TTM) | $20.5M |
Shares Outstanding | 51.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.90 |
EPS | $-2.36 |
Book Value | $7.15 |
P/E Ratio | -10.7x |
Price/Sales (TTM) | 63.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -591.10% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
